Matches in Wikidata for { <http://www.wikidata.org/entity/Q102151016> ?p ?o ?g. }
Showing items 1 to 32 of
32
with 100 items per page.
- Q102151016 description "2020 ވަނަ އަހަރުގެ ނޮވެމްބަރުމަހުގެ 16ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q102151016 description "artículu científicu espublizáu en payares de 2020" @default.
- Q102151016 description "im November 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q102151016 description "scientific article published on 16 November 2020" @default.
- Q102151016 description "wetenschappelijk artikel" @default.
- Q102151016 description "наукова стаття, опублікована 16 листопада 2020" @default.
- Q102151016 name "Pharmacological influencing of cholinergic anti-inflammatory pathway in infectious diseases and inflammatory pathologies" @default.
- Q102151016 name "Pharmacological influencing of cholinergic anti-inflammatory pathway in infectious diseases and inflammatory pathologies" @default.
- Q102151016 name "Pharmacological influencing of cholinergic anti-inflammatory pathway in infectious diseases and inflammatory pathologies" @default.
- Q102151016 type Item @default.
- Q102151016 label "Pharmacological influencing of cholinergic anti-inflammatory pathway in infectious diseases and inflammatory pathologies" @default.
- Q102151016 label "Pharmacological influencing of cholinergic anti-inflammatory pathway in infectious diseases and inflammatory pathologies" @default.
- Q102151016 label "Pharmacological influencing of cholinergic anti-inflammatory pathway in infectious diseases and inflammatory pathologies" @default.
- Q102151016 prefLabel "Pharmacological influencing of cholinergic anti-inflammatory pathway in infectious diseases and inflammatory pathologies" @default.
- Q102151016 prefLabel "Pharmacological influencing of cholinergic anti-inflammatory pathway in infectious diseases and inflammatory pathologies" @default.
- Q102151016 prefLabel "Pharmacological influencing of cholinergic anti-inflammatory pathway in infectious diseases and inflammatory pathologies" @default.
- Q102151016 P1433 Q102151016-115AC43A-07B4-43AC-9C36-9B4AC70B63F5 @default.
- Q102151016 P1476 Q102151016-7931C293-5829-45A8-B74C-3805C056EB6F @default.
- Q102151016 P2093 Q102151016-25E9C143-5724-40CF-9CA1-600FCE71960B @default.
- Q102151016 P31 Q102151016-AC1C62E3-EC68-490F-91C5-EE0AD319773D @default.
- Q102151016 P356 Q102151016-12C418D9-BF6D-4882-B5C4-9540300AFD97 @default.
- Q102151016 P577 Q102151016-5912DA57-9FCA-4A50-9CF7-EAB8C2448F60 @default.
- Q102151016 P698 Q102151016-85252589-B752-47F4-8BB3-E43F58455526 @default.
- Q102151016 P356 1389557520666201117111715 @default.
- Q102151016 P698 33208075 @default.
- Q102151016 P1433 Q3314982 @default.
- Q102151016 P1476 "Pharmacological influencing of cholinergic anti-inflammatory pathway in infectious diseases and inflammatory pathologies" @default.
- Q102151016 P2093 "Miroslav Pohanka" @default.
- Q102151016 P31 Q13442814 @default.
- Q102151016 P356 "10.2174/1389557520666201117111715" @default.
- Q102151016 P577 "2020-11-16T00:00:00Z" @default.
- Q102151016 P698 "33208075" @default.